BANK VONTOBEL/CALL/SANOFI/94/0.1/21.06.24 Share Price

Warrant

DE000VU9N0Q0

Market Closed - Deutsche Boerse AG 18:43:58 07/06/2024 BST
0.03 EUR +30.43% Intraday chart for BANK VONTOBEL/CALL/SANOFI/94/0.1/21.06.24
Current month+25.00%
1 month-62.50%
Date Price Change
07/06/24 0.03 +30.43%
06/06/24 0.023 -11.54%
05/06/24 0.026 -16.13%
04/06/24 0.031 -3.13%
03/06/24 0.032 +33.33%

Delayed Quote Deutsche Boerse AG

Last update June 07, 2024 at 06:43 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VU9N0Q
ISINDE000VU9N0Q0
Date issued 07/07/2023
Strike 94
Maturity 21/06/2024 (13 Days)
Parity 10 : 1
Emission price 0.94
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.53
Lowest since issue 0.01
Spread 0.016
Spread %34.78%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.13 EUR
Average target price
108.2 EUR
Spread / Average Target
+18.72%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW